Grard A. P. Nieuwenhuijzen

Grard A. P. Nieuwenhuijzen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Grard A. P. Nieuwenhuijzen sits on this spectrum.

Grard A. P. Nieuwenhuijzen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Grard A. P. Nieuwenhuijzen sits on this spectrum.

Overview

Best Publications

• Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

  Joel Shapiro;J Jan B van Lanschot;Maarten C C M Hulshof;Pieter van Hagen

  2335
  Citations

• Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

  Mila Donker;Geertjan van Tienhoven;Marieke E Straver;Philip Meijnen

  1882
  Citations

• Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.

  Renu R Bahadoer;Esmée A Dijkstra;Boudewijn van Etten;Corrie A M Marijnen;Corrie A M Marijnen

  1109
  Citations

• Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure.

  R.M.H. Roumen;T. Hendriks;J. van der Ven-Jongekrijg;G.A. Nieuwenhuijzen

  894
  Citations

• Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial

  Ben M Eyck;J Jan B van Lanschot;J Jan B van Lanschot;Maarten C C M Hulshof;Berend J van der Wilk

  480
  Citations

• Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy

  M.P. Schijven;A.J.J.M. Vingerhoets;H.J.T. Rutten;G.A.P. Nieuwenhuijzen

  345
  Citations

• Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study

  W.J. Louwman;M.L.G. Janssen-Heijnen;S. Houterman;A.C. Voogd

  266
  Citations

• Oncological outcome of malignant colonic obstruction in the Dutch Stent-In 2 trial

  D. A. M. Sloothaak;M. W. van den Berg;M. G. W. Dijkgraaf;P. Fockens

  246
  Citations

• Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.

  Bo Jan Noordman;Manon C W Spaander;Roelf Valkema;Bas P L Wijnhoven

  242
  Citations

• Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer.

  Raphaëla C. Dresen;Marleen J. Gosens;Hendrik Martijn;Grard A. Nieuwenhuijzen

  240
  Citations

• Reduction of Postoperative Ileus by Early Enteral Nutrition in Patients Undergoing Major Rectal Surgery Prospective, Randomized, Controlled Trial

  Petra G. Boelens;Fanny F. B. M. Heesakkers;Misha D. P. Luyer;Kevin W. Y. van Barneveld

  240
  Citations

• Laparoscopic cholecystectomy versus percutaneous catheter drainage for acute cholecystitis in high risk patients (CHOCOLATE): multicentre randomised clinical trial

  Charlotte S Loozen;Hjalmar C van Santvoort;Peter van Duijvendijk;Marc Gh Besselink

  240
  Citations

• Learning Curve and Associated Morbidity of Minimally Invasive Esophagectomy: A Retrospective Multicenter Study

  Frans van Workum;Marianne H. B. C. Stenstra;Gijs H. K. Berkelmans;Annelijn E. Slaman

  234
  Citations

• Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial

  Bo Jan Noordman;Bas P. L. Wijnhoven;Sjoerd M. Lagarde;Jurjen J. Boonstra

  232
  Citations

• Defining Benchmarks for Transthoracic Esophagectomy: A Multicenter Analysis of Total Minimally Invasive Esophagectomy in Low Risk Patients.

  Henner M. Schmidt;Susanne S. Gisbertz;Johnny Moons;Ioannis Rouvelas

  225
  Citations

• Circumferential Margin Involvement Is the Crucial Prognostic Factor after Multimodality Treatment in Patients with Locally Advanced Rectal Carcinoma

  Marleen J.E.M. Gosens;René A. Klaassen;Ivonne Tan-Go;Harm J.T. Rutten

  203
  Citations

• Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study.

  Leonora S F Boogerd;Charlotte E S Hoogstins;Dennis P Schaap;Miranda Kusters

  188
  Citations

• Laparoscopic Versus Open Gastrectomy for Gastric Cancer (LOGICA): A Multicenter Randomized Clinical Trial

  Arjen van der Veen;Hylke J F Brenkman;Maarten F J Seesing;Leonie Haverkamp

  169
  Citations

• Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands

  Johan L. Dikken;Johan L. Dikken;Valery E. Lemmens;Michel W.J.M. Wouters;Bas P. Wijnhoven

  166
  Citations

• Clinical management of women with metastatic breast cancer: a descriptive study according to age group.

  Klaartje Manders;Lonneke V van de Poll-Franse;Geert-Jan Creemers;Gerard Vreugdenhil

  165
  Citations